Biosimilars Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, October 4, 2016 /EINPresswire.com/ -- The Biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment. Biosimilars are seen as the key weapon to curbing soaring healthcare costs globally. The major factor that is driving the market for biosimilars industry is the fact that major biologics are nearing the patent cliff. Further, the lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to curb healthcare costs globally, increasing nationwide government initiatives, and the strong pipeline for the biosimilar drugs is expected to fuel the biosimilars industry. On the other hand, high manufacturing complexities and costs, stringent regulatory requirements in countries and operational challenges are restricting the growth of the biosimilars market.

Complete Report @ https://www.wiseguyreports.com/reports/668723-global-biosimilars-market-and-and-pipeline-analysis

Key Highlights of the Report

Biosimilars Market - By Product Type
• The erythropoietin (EPO) captures maximum share of the global biosmilars market.

• The Granulocyte- Colony Stimulating Factor (G-CSF) market is expected to cross US$ 6 Billion mark by 2021.

• The Human Growth Hormone (HGH) biosimilars market is expected to grow with a double digit CAGR during the period 2016 - 2021.

• The monoclonal antibody is expected to show the highest growth rate during the period 2016 - 2021.

• The insulin and interferon product segment each accounted for single digit share of the global biosimilars market respectively in 2015.

Biosimilars Market - By Applications
• Among various application segments of biosimilar market, blood disorders and oncology together accounted for over 55% share of the global biosimilars market in 2015.

• Growth hormone deficiencies application is expected to show double digit CAGR during the period 2016 - 2021.

• The chronic and autoimmune disorders captured XX% share of the biosmilars market in 2015.


Biosimilars Market - By Country Wise
• The market for biosimilars in the U.S. has gained momentum after the launch of Novartis’ Zarxio in September 2015.

• In the European countries, Germany is at the forefront with around XX% share of the biosimilars market in 2015 followed by France with XX% share in the same year.

• China accounted for XX% share of the global biosimilar market in 2015.

• India is seen as a key player in the biosimilar space with an exceptionally high number of approvals granted in the last decade compared to the global average.

• South Korea captured XX% of the global biosimilar market in 2015 being closely followed by Brazil with XX% share in the same year.

Get sample report @ https://www.wiseguyreports.com/sample-request/668723-global-biosimilars-market-and-and-pipeline-analysis

This 177 Page report with 74 Figures and 27 Tables is analyzed from 6 viewpoints:

1. Global Biosimilars Market and Forecast - By Product Type

2. Global Biosimilars Market and Forecast - By Applications

3. Global Biosimilars Market and Forecast - By Country Wise

4. Global Biosimilars Company - Profile, Revenue, Approved and Pipeline Biosimilars Analysis

5. Country with Biosimilar Guideline and Published Year

6. Global Biosimilars Market - Driving Factors and Challenges

Global Biosimilars Market and Forecast - 7 Product Types Covered
1. Erythropoietin (EPO)
2. Human Growth Hormone (HGH)
3. Granulocyte- Colony Stimulating Factor (G-CSF)
4. Monoclonal Antibody (mAb)
5. Insulin
6. Interferon (IFN)
7. Others

Global Biosimilars Market and Forecast - 5 Applications Covered
1. Oncology
2. Blood Disorders
3. Growth Hormone Deficiencies
4. Chronic and Autoimmune Disorders
5. Other Applications

Global Biosimilars Market and Forecast - 16 Countries Covered
1. United States
2. Canada
3. Argentina
4. Germany
5. France
6. Italy
7. Spain
8. United Kingdom
9. China
10. Japan
11. India
12. South Korea
13. Australia
14. Brazil
15. Mexico
16. Rest of the World

Global Biosimilars Company Analysis - 13 Companies Covered
1. Biocad
2. Celltrion Inc.
3. Dong-A Socio Group
4. Pfizer Inc.
5. Intas Pharmaceuticals Ltd.
6. Sandoz International GmbH - A Novartis Company
7. Stada Arzneimittel AG
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc.
10. Biocon
11. Dr. Reddy’s Laboratories
12. Mylan
13. Merck KGaA

Have any query @ https://www.wiseguyreports.com/enquiry/668723-global-biosimilars-market-and-and-pipeline-analysis

Table of Content
1. Executive Summary

2. Global Biosimilars Market and Forecast to 2021

3. Global Biosimilars Market Share and Forecast to 2021

3.1 Global Biosimilars Market Share and Forecast - By Product Type
3.2 Global Biosimilars Market Share and Forecast - By Applications
3.3 Global Biosimilars Market Share and Forecast - By Country Wise

4. Global Biosimilars Market and Forecast - By Product Type

4.1 Erythropoietin (EPO) Biosimilars Market and Forecast
4.2 Human Growth Hormone (HGH) Biosimilars Market and Forecast
4.3 Granulocyte - Colony Stimulating Factor (G-CSF) Biosimilars Market and Forecast
4.4 Monoclonal Antibody (mAb) Biosimilars Market and Forecast
4.5 Insulin Biosimilars Market and Forecast
4.6 Interferon (IFN) Biosimilars Market and Forecast
4.7 Others Biosimilars Market and Forecast

5. Global Biosimilars Market and Forecast - By Applications

5.1 Oncology Biosimilars Market and Forecast
5.2 Blood Disorders Biosimilars Market and Forecast
5.3 Growth Hormone Deficiencies Biosimilars Market and Forecast
5.4 Chronic and Autoimmune Disorders Biosimilars Market and Forecast
5.5 Other Applications Biosimilars Market and Forecast

6. Global Biosimilars Market and Forecast - By Country Wise

6.1 United States Biosimilars Market and Forecast
6.2 Canada Biosimilars Market and Forecast
6.3 Argentina Biosimilars Market and Forecast
6.4 Germany Biosimilars Market and Forecast

6.4.1 Reimbursement of Biosimilars in Germany

6.5 France Biosimilars Market and Forecast
6.5.1 Reimbursement of Biosimilars in France

6.6 Italy Biosimilars Market and Forecast
6.6.1 Pricing and Reimbursement of Biosimilars in Italy

6.7 Spain Biosimilars Market and Forecast
6.8 United Kingdom Biosimilars Market and Forecast

6.8.1 Reimbursement of Biosimilars in United Kingdom

6.9 China Biosimilars Market and Forecast
6.10 Japan Biosimilars Market and Forecast
6.11 India Biosimilars Market and Forecast
Continued…

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=668723

Follow Us:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.